(Q74100933)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11427284%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

title

Intranasal immunisation with influenza-ISCOM induces strong mucosal as well as systemic antibody and cytotoxic T-lymphocyte responses (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11427284%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

author name string

S Sjölander

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11427284%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

D Drane

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11427284%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

R Davis

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11427284%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

L Beezum

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11427284%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

M Pearse

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11427284%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

J Cox

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11427284%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

language of work or name

English

0 references

publication date

1 July 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11427284%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11427284%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11427284%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

page(s)

4072-4080

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11427284%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

issue

28-29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11427284%20AND%20SRC:MED&resulttype=core&format=json

The mucosal immune system: from fundamental concepts to vaccine development

8 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900110-4

7 January 2021

Nasal delivery of vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900110-4

7 January 2021

Mucosal immunity: implications for vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900110-4

7 January 2021

Adjuvants--a classification and review of their modes of action

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900110-4

7 January 2021

The adjuvants MF59 and LT-K63 enhance the mucosal and systemic immunogenicity of subunit influenza vaccine administered intranasally in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900110-4

7 January 2021

A novel influenza subunit vaccine composed of liposome-encapsulated haemagglutinin/neuraminidase and IL-2 or GM-CSF. I. Vaccine characterization and efficacy studies in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900110-4

7 January 2021

CpG DNA, a novel immune enhancer for systemic and mucosal immunization with influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900110-4

7 January 2021

ISCOMs (immunostimulating complexes): the first decade

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900110-4

7 January 2021

ISCOMs and other saponin based adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900110-4

7 January 2021

Cellular immune responses in the murine lung to local immunization with influenza A virus glycoproteins in micelles and immunostimulatory complexes (iscoms).

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900110-4

7 January 2021

An experimental influenza subunit vaccine (iscom): induction of protective immunity to challenge infection in mice after intranasal or subcutaneous administration

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900110-4

7 January 2021

Linkage of a fusion peptide to a CTL epitope from the nucleoprotein of measles virus enables incorporation into ISCOMs and induction of CTL responses following intranasal immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900110-4

7 January 2021

Intranasal immunization of mice with Echinococcus granulosus surface antigens iscoms evokes a strong immune response, biased towards glucidic epitopes.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900110-4

7 January 2021

A mucosal IgA response, but no systemic antibody response, is evoked by intranasal immunisation of dogs with Echinococcus granulosus surface antigens iscoms

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900110-4

7 January 2021

Intranasal immunization of mice with herpes simplex virus type 2 recombinant gD2: the effect of adjuvants on mucosal and serum antibody responses

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900110-4

7 January 2021

The immunostimulating complex (ISCOM) is an efficient mucosal delivery system for respiratory syncytial virus (RSV) envelope antigens inducing high local and systemic antibody responses

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900110-4

7 January 2021

The adjuvant effect of a non-toxic mutant of heat-labile enterotoxin of Escherichia coli for the induction of measles virus-specific CTL responses after intranasal co-immunization with a synthetic peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900110-4

7 January 2021

Iscom and iscom-matrix enhance by intranasal route the IgA responses to OVA and rCTB in local and remote mucosal secretions

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900110-4

7 January 2021

Intranasal immunization of mice against influenza with synthetic peptides anchored to proteosomes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900110-4

7 January 2021

Lectin-bearing polymerized liposomes as potential oral vaccine carriers

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900110-4

7 January 2021

Immune stimulating complexes as mucosal vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900110-4

7 January 2021

Induction of Th1 and Th2 CD4+ T cell responses by oral or parenteral immunization with ISCOMS.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900110-4

7 January 2021

10.1016/S0264-410X(01)00110-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11427284%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

1 reference